# Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.

> **NCT02413515** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 278 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nifedipine (Adalat GITS, BAY1040)

## Key facts

- **NCT ID:** NCT02413515
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-26
- **Primary completion:** 2016-08-08
- **Final completion:** 2016-08-08
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2017-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02413515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02413515, "Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02413515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*